Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents
This review explores the role of neuroinflammation in Alzheimer’s disease (AD) and the potential therapeutic application of anti-inflammatory agents. It highlights how astrocytes, microglia, peripheral immune cells, and microRNAs contribute to neuroinflammatory responses that exacerbate AD progression. Anti-inflammatory drugs may offer neuroprotection by modulating these pathways, potentially slowing disease progression